Clinical trial focuses on reducing overactive immune response in COVID-19
School of Medicine researchers are investigating whether a drug approved by the Food and Drug Administration to treat rare diseases of an overactive immune system could help critically ill patients hospitalized with COVID-19.
Vaccine prevents pneumonia, elicits high levels of protective antibodies
Researchers at Washington University School of Medicine in St. Louis have created a COVID-19 vaccine candidate from a replicating virus. This experimental vaccine has proven effective at preventing pneumonia in mice.
Washington University, St. Louis County collaborate on COVID-19 survey
Up to 5,000 St. Louis County residents will be invited to participate in a survey and testing regarding COVID-19 to help gauge the impact the coronavirus has had on the county’s residents. Washington University in St. Louis and the St. Louis County Department of Public Health are leading the project.
Social work’s role in the health, well-being of LGBTQ people in China
As China’s government seeks solutions to social problems related to an evolving society, professional social work is increasingly entering new areas, including migrant and aging services, and is poised to take on a larger role in assisting lesbian, gay, bisexual, transgender and queer people, say two experts from the Brown School at Washington University in St. Louis.
Pandemic lessons from 2-1-1
There have been more than 3.5 million requests for assistance to 2-1-1 help lines around the United States since the coronavirus pandemic hit this spring. The impact was immediate and dramatic, said a Brown School researcher who tracks calls to 2-1-1 help lines across the U.S.
Alzheimer’s protein in blood indicates early brain changes
Researchers at Washington University School of Medicine have shown that levels of a specific protein in the blood rise as amyloid plaques form in the brain. The discovery could pave the way toward a blood-based test to diagnose Alzheimer’s disease before symptoms appear.
Lab-made virus mimics COVID-19 virus
To help efforts to find drugs and vaccines for COVID-19, researchers at Washington University School of Medicine developed a hybrid virus that will enable more scientists to enter the fight against the pandemic. The researchers genetically modified a mild virus.
Gut bacteria protect against mosquito-borne viral illness
A new study from Washington University School of Medicine has found that mice infected with Chikungunya virus get less sick and are less likely to transmit the virus to mosquitoes if they have healthy gut microbiomes.
Global wildlife surveillance could provide early warning for next pandemic
A team of wildlife biologists and infectious disease experts, including some at the School of Medicine, propose in an article published in Science a decentralized, global wildlife biosurveillance system to identify animal viruses that have the potential to cause human disease – before the next pandemic emerges.
Search for cure for common parasitic infection focus of $5.5 million NIH grant
Parasitologist L. David Sibley at the School of Medicine is leading an international effort to find drugs to cure toxoplasmosis, a parasitic disease characterized by vision problems and brain complications.
Older Stories